This article was originally published in The Rose Sheet
The European Commission says it plans to clear up some of the uncertainties about the animal testing ban when the ban goes into effect March 11. Market researcher Packaged Facts says oral-care product sales in the US grew to near $5 billion annually.
You may also be interested in...
While it appears inevitable that the European Commission’s full ban on testing cosmetic ingredients on animals will proceed starting March 11 as dictated by the Cosmetics Directive, how the EC and member states will interpret and enforce the ban remains to be seen. Consulting firm Technology Sciences Group believes the regulation may be more flexible, and less onerous, than anticipated.
Shanghai Henlius Biotech has announced that China’s NMPA has accepted the firm’s filing for its HLX14 denosumab biosimilar. Meanwhile, the company has also announced dosing the first patient in a Phase II clinical trial of its novel HLX10 anti-PD-1 monoclonal antibody.
The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.